Production (Stage)
Cue Biopharma, Inc.
CUE
$0.594
-$0.008-1.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -39.94% | -27.86% | 7.96% | -26.81% | -15.93% |
| Total Receivables | -- | -70.02% | 70.66% | 31.93% | -17.55% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 133.91% | -52.20% | -16.80% | -9.64% | 134.55% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -36.63% | -32.53% | 9.90% | -24.11% | -13.19% |
|
|
|||||
| Total Current Assets | -36.63% | -32.53% | 9.90% | -24.11% | -13.19% |
| Net Property, Plant & Equipment | -15.06% | 5.15% | -15.94% | -13.43% | -11.11% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.05% | -25.02% | -0.07% | -0.10% | -0.10% |
| Total Assets | -30.87% | -28.16% | 5.86% | -21.54% | -12.32% |
|
|
|||||
| Total Accounts Payable | 34.04% | -56.39% | 65.75% | -0.33% | 11.94% |
| Total Accrued Expenses | 45.46% | -9.10% | -29.88% | -12.40% | 25.89% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -11.74% | 14.80% | -2.24% | -2.20% | -2.16% |
| Total Finance Division Other Current Liabilities | 529.41% | -67.18% | -73.46% | -45.47% | -15.25% |
| Total Other Current Liabilities | 529.41% | -67.18% | -73.46% | -45.47% | -15.25% |
| Total Current Liabilities | 13.21% | -18.47% | 2.01% | -9.02% | 5.91% |
|
|
|||||
| Total Current Liabilities | 13.21% | -18.47% | 2.01% | -9.02% | 5.91% |
| Long-Term Debt | -- | -- | -41.91% | -29.53% | -22.80% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -82.45% | -24.36% | -32.42% | -23.92% | -18.44% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.68% | -24.44% | -6.10% | -13.41% | -2.18% |
|
|
|||||
| Common Stock & APIC | 0.37% | 0.46% | 3.59% | 0.51% | 1.57% |
| Retained Earnings | -3.59% | -2.86% | -2.68% | -3.24% | -4.10% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -62.40% | -31.01% | 17.32% | -28.02% | -19.00% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -62.40% | -31.01% | 17.32% | -28.02% | -19.00% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -62.40% | -31.01% | 17.32% | -28.02% | -19.00% |
|
|
|||||